Dosage Forms - Innovation and Future Perspectives 2023
DOI: 10.5772/intechopen.108246
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Drug Metabolism Studies Using Human Liver Microsomes

Abstract: Metabolism of most pharmaceutical drugs occurs in the liver. In drug metabolism, enzymes convert drugs to highly water-soluble metabolites to facilitate excretion from the body. Thus, in vitro models for studying drug metabolism usually target hepatocytes or subcellular liver fractions like microsomes, cytosols, or S9 fractions with high concentrations of specific enzymes. The most popular subcellular fraction used during drug discovery tends to be the microsomes, as these are easy to prepare and store, are am… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 121 publications
0
1
0
Order By: Relevance
“…9,14 Phase I enzymes have garnered attention in the development of enzyme-directed uorescence chemosensors, owing to their inclusion of pharmacologically signicant enzymes such as esterase, cytochrome P450 family, monoamine oxidase, nitroreductase, aldehyde dehydrogenase, and glycosidase. 10,15 These enzymes actively participate in the metabolism and activation of numerous prodrugs, with their overexpression in cancer cells marking them as potential biomarkers for early-stage cancer diagnosis and monitoring therapeutic efficacy of cancer drugs. [16][17][18][19] Anticipating a surge in cancer cases, the World Health Organization predicts 24 million new cases and 14.4 million annual deaths by 2035.…”
Section: Introductionmentioning
confidence: 99%
“…9,14 Phase I enzymes have garnered attention in the development of enzyme-directed uorescence chemosensors, owing to their inclusion of pharmacologically signicant enzymes such as esterase, cytochrome P450 family, monoamine oxidase, nitroreductase, aldehyde dehydrogenase, and glycosidase. 10,15 These enzymes actively participate in the metabolism and activation of numerous prodrugs, with their overexpression in cancer cells marking them as potential biomarkers for early-stage cancer diagnosis and monitoring therapeutic efficacy of cancer drugs. [16][17][18][19] Anticipating a surge in cancer cases, the World Health Organization predicts 24 million new cases and 14.4 million annual deaths by 2035.…”
Section: Introductionmentioning
confidence: 99%
“…HLMs are derived from the liver's endoplasmic reticulum through differential high-speed centrifugation. This technique allows for the isolation of the subcellular fractions that contain important enzymes involved in hepatic drug metabolism, including cytochrome P450s and UGTs (UDP-glucuronosyltransferases) [9].…”
Section: Introductionmentioning
confidence: 99%